2024 annual financial data
Kura Oncology 2024 Operating margin
Direct answer
Operating margin was -358.55%.
Operating income was -193,195,000 USD and net income was -173,983,000 USD.
Operating cash flow was 134,317,000 USD.
Get free Kura Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 53,883,000 USD
- Operating income
- -193,195,000 USD
- Net income
- -173,983,000 USD
- Operating cash flow
- 134,317,000 USD